THIS PRESENTATION IS BASED UPON 3D PRINTING OF DRUGS & HOW THIS TECHNIQUE IS USED IN THE MODERN PHARMACEUTICAL FIELD...
HOPE IT WILL DEFINITELY REVOLUTIONIZED THE PHARMACEUTICAL FIELD...
PLEASE HIT LIKE IF U LIKE OUR WORK & PLEASE LEAVE COMMENT...
THANK YOU ;)
3D PRINTING: ENVISIONING A NEW ERA IN PHARMACEUTICAL FIELD
1. 3D PRINTING: ENVISIONING A
NEW ERA IN PHARMACEUTICAL
FIELD
PRESENTED BY: arnab mukherjee
SNEHASHIS SARKAr
COURSE: B. PHARM.
2. INTRODUCTION
3D Printed medicines
are revolutionising the
pharmaceutical market
as potential tools to
achieve personalised
treatments adapted to the
specific requirements of
each patient
3. HISTORY
3D printing is not as new
as we all think. In 2009
when the FDM patents
expired, 3D printing
became such a hot topic
that it was easy to
believe it was a brand
new innovation.
4. WHAT IS 3D PRINTING
Three-dimensional (3D)
printing is a process of
creating 3D objects,
where materials are
deposited layer over layer
using a computer-driven
process based on a digital
model.
5. EVOLUTION OF 3D
PRINTING
Fashion, toys
Automobile industry
Computer parts
Architectural industry
Medical
Pharmaceuticals, first
reported 3D pill in 1996
6. HOW IT CAME TO
PHARMACEUTICAL FIELD?
3D Printing
Technology Came into
Pharmaceutical Field
first 3D printed object,
a tiny cup for eye wash
Invented by Chuck
Hull in 1984
8. 3D PRINTING METHODS
SOLID FREEFORM
FABRICATION (SFF)
PRINTING
BASED INJECT
SYSTEMS
DROP-ON-
DEMAND
PRINTING
(DOD)
DROP-ON-
SOLID
PRINTING
DROP-ON-
DROP
PRINTING
CONTINUO
US INJECT
SYSTEM
(CIJ)
NOZZLE-
BASED
DEPOSITION
SYSTEMS
WITH
MELTING
MATERIALS
FUSED-
DEPOSITION
MODELLING
(FDM)
WITHOUT
MELTING
MATERIALS
PRESSURE-
ASISTED
MICROSYRIN
GE (PAM)
LASER-
BASED
WRITTING
SYSTEMS
STEREOLOT
HOGRAPHY
(SLA)
16. POLYVINYLALCOHOL
Polyvinyl alcohol (PVA)
is a thermoplastic
synthetic polymer with
good solubility in water,
low solubility in ethanol
and insoluble in many
organic solvents
17. POLY LACTIC ACID
Polylactic acid is a
biodegradable polymer
recognized as safe by
Food and Drug
Administration (FDA)
and suitable for different
medical applications.
19. SMART MATERIALS FOR DRUG
DFELIVERY
Shape memory polymer
(SMP)s are considered
active polymers, as they
change from a temporary
shape to their original,
permanent shape upon
exposure to a stimulus.
Eg: methacrylate,
polyurethane.
24. IN INDUSTRIES
IN WORLD-
•Hewlett-Packard (HP)
•Proto Labs
•Hershey’s
IN INDIA-
•Raspberry Pi and Arduino
•Nissan, Mahindra
•GKN Aerospace
•Aprecia Pharmaceuticals Company
25. ADVANTAGES
•Accurate dosing, lower side effects, better
paediatric adherence.
•Manufacture as per need and preference.
•No need for long shelf life.
•Individualized multi drug polypills.
27. CONCLUSION
With continued research, it can be
believed that personalized
medicine will reach new levels of
possibility, and pharmacies will
be revolutionized by this
particular application of 3D
printing.
28. REFERENCES
•Norman J., Madurawe R. D., Moore C. M. V., Khan M. A.,
Khairuzzaman A., A new chapter in pharmaceutical
manufacturing: 3D-printed drug products, 2017, 108, 39–50.
• Andrea Alice Konta Marta García-Piña and Dolores R.
Serrano, Personalised 3D Printed Medicines: WhichTechniques
and Polymers Are More Successful? , 2017, 1.
•Fina F., Goyanes A., Gaisford S., Basit A.W., Selective laser
sintering (SLS) 3D printing ofmedicines. 2017, 529, 285–293.
•Woodruff M.A., Hutmacher W.D., The return of a forgotten
polymer—Polycaprolactone in the 21st Century. Prog. Polym.
Sci. 2010, 35, 1217–1256